The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2861925)

Published in Clin Ophthalmol on April 26, 2010

Authors

Anita R Shirodkar1, Harry W Flynn, Kyle Alliman, Geeta A Lalwani, Chrisfouad Alabiad, Andrew A Moshfeghi, Darlene Miller

Author Affiliations

1: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.

Articles cited by this

Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol (1995) 10.80

Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg (2007) 3.85

Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology (2002) 3.47

Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol (1996) 3.28

Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol (1996) 2.76

Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg (2008) 2.39

Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79

Intracameral antibiotics: questions for the United States based on prospective studies. J Cataract Refract Surg (2008) 1.42

Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery. J Cataract Refract Surg (2009) 1.17

Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol (2000) 1.13

A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol (2007) 1.04

Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol (2004) 1.04

Postoperative endophthalmitis associated with sutured versus unsutured clear corneal cataract incisions. Br J Ophthalmol (2007) 1.04

Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am J Ophthalmol (2006) 1.02

Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones. J Cataract Refract Surg (2009) 0.98

Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging (2007) 0.97

Patterns of perioperative prophylaxis for cataract surgery in Canada. Can J Ophthalmol (2007) 0.93

A survey of measures used for the prevention of postoperative endophthalmitis after cataract surgery in the United Kingdom. Eye (Lond) (2006) 0.86

A retrospective study of the incidence of culture-positive endophthalmitis after cataract surgery and the use of preoperative antibiotics. Ophthalmic Surg Lasers Imaging (2007) 0.83

Articles by these authors

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol (2007) 8.12

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging (2005) 7.31

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol (2009) 5.41

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina (2006) 3.48

Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina (2014) 3.41

Evolving guidelines for intravitreous injections. Retina (2004) 3.39

Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol (2004) 2.98

Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina (2011) 2.97

Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol (2013) 2.90

Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol (2005) 2.66

Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology (2012) 2.41

Ranibizumab: Phase III clinical trial results. Ophthalmol Clin North Am (2006) 2.25

Ocular flora and their antibiotic resistance patterns in the midwest: a prospective study of patients undergoing cataract surgery. Am J Ophthalmol (2012) 2.18

Retained lens fragments after cataract surgery: outcomes of same-day versus later pars plana vitrectomy. Am J Ophthalmol (2013) 2.13

Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery? Retina (2014) 2.11

The diagnostic utility of anterior chamber paracentesis with polymerase chain reaction in anterior uveitis. Am J Ophthalmol (2013) 2.08

Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol (2006) 2.05

In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol (2004) 2.00

Visual and anatomical outcomes of macular epiretinal membrane peeling after previous rhegmatogenous retinal detachment repair. Retina (2015) 1.98

Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surg Lasers Imaging Retina (2013) 1.98

Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol (2011) 1.92

Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol (2004) 1.91

Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol (2004) 1.91

Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86

Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol (2011) 1.83

Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am J Ophthalmol (2010) 1.82

Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79

Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina (2008) 1.75

Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol (2004) 1.74

Fungal keratitis associated with non-therapeutic soft contact lenses. Am J Ophthalmol (2006) 1.67

ENDOPHTHALMITIS CAUSED BY PSEUDOMONAS AERUGINOSA: Clinical Features, Antibiotic Susceptibilities, and Treatment Outcomes. Retina (2015) 1.58

Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina (2008) 1.57

Photoreceptor inner/outer segment defect imaging by spectral domain OCT and visual prognosis after macular hole surgery. Invest Ophthalmol Vis Sci (2009) 1.54

Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology (2008) 1.51

Anterior chamber and vitreous concordance in endophthalmitis: implications for prophylaxis. Arch Ophthalmol (2010) 1.50

Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci (2011) 1.50

Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol (2009) 1.48

Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome. Eur Heart J (2007) 1.48

An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol (2012) 1.45

Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections. Am J Ophthalmol (2011) 1.44

Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch Ophthalmol (2003) 1.44

The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy. Retina (2011) 1.39

Reducing the risk of endophthalmitis following intravitreal injections. Retina (2007) 1.39

Spectral-domain optical coherence tomography appearance of preretinal aggregation of intravitreal antibiotics. Retina (2010) 1.38

Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology (2003) 1.36

Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2010) 1.33

Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol (2009) 1.33

Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes. Ophthalmology (2003) 1.29

Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophthalmol (2009) 1.28

Advanced fusarium keratitis progressing to endophthalmitis. Cornea (2003) 1.28

Update on bacterial conjunctivitis in South Florida. Ophthalmology (2007) 1.27

Macular thickness measurements in normal eyes using spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging (2008) 1.26

Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol (2008) 1.24

Endophthalmitis caused by enterococcus faecalis: antibiotic selection and treatment outcomes. Ophthalmology (2003) 1.21

Colletotrichum keratitis. Am J Ophthalmol (2002) 1.21

Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes. Retina (2011) 1.20

Update on retinal detachment surgery. Curr Opin Ophthalmol (2013) 1.19

Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology (2002) 1.18

Anti-VEGF Treatment Strategies for Wet AMD. J Ophthalmol (2012) 1.17

Epidemiology and visual outcomes in patients with infectious scleritis. Cornea (2013) 1.15

Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15

Three-dimensional spectral-domain optical coherence tomography images of the retina in the presence of epiretinal membranes. Am J Ophthalmol (2008) 1.14

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol (2010) 1.14

Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol (2004) 1.12

Surgical management of non-metallic and non-magnetic metallic intraocular foreign bodies. Ophthalmic Surg Lasers Imaging (2005) 1.12

Persistent outer retinal defect after successful macular hole repair. Am J Ophthalmol (2005) 1.12

In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol (2006) 1.11

Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol (2003) 1.11

Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome. J Ophthalmic Inflamm Infect (2013) 1.09

Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration. Retina (2009) 1.09

Documentation by spectral domain OCT of spontaneous closure of idiopathic macular holes. Ophthalmic Surg Lasers Imaging (2007) 1.09

Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PLoS One (2011) 1.09

Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Can J Ophthalmol (2013) 1.08

Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol (2002) 1.08

Voriconazole and fungal keratitis: a report of two treatment failures. J Ocul Pharmacol Ther (2006) 1.08